Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/65528
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Abad, Sonia |
dc.contributor.author | Junyent Herena, Fèlix |
dc.contributor.author | Auladell i Costa, M. Carme |
dc.contributor.author | Pubill Sánchez, David |
dc.contributor.author | Pallàs i Llibería, Mercè, 1964- |
dc.contributor.author | Camarasa García, Jordi |
dc.contributor.author | Escubedo Rafa, Elena |
dc.contributor.author | Camins Espuny, Antoni |
dc.date | 2015-05-13T12:38:54Z |
dc.date | 2015-05-13T12:38:54Z |
dc.date | 2014-06-28 |
dc.date | 2015-05-13T12:38:54Z |
dc.identifier.citation | 0278-5846 |
dc.identifier.citation | 644120 |
dc.identifier.uri | http://hdl.handle.net/2445/65528 |
dc.format | 12 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier B.V. |
dc.relation | Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.pnpbp.2014.06.007 |
dc.relation | Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2014, vol. 54, p. 231-242 |
dc.relation | http://dx.doi.org/10.1016/j.pnpbp.2014.06.007 |
dc.rights | (c) Elsevier B.V., 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Al·lucinògens |
dc.subject | Amfetamines |
dc.subject | Compostos heterocíclics |
dc.subject | Epilèpsia |
dc.subject | Neurotoxicologia |
dc.subject | Ratolins (Animals de laboratori) |
dc.subject | Sistema nerviós central |
dc.subject | Hallucinogenic drugs |
dc.subject | Amphetamines |
dc.subject | Heterocyclic compounds |
dc.subject | Epilepsy |
dc.subject | Neurotoxicology |
dc.subject | Mice (Laboratory animals) |
dc.subject | Central nervous system |
dc.title | 3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |